MedTrace Logo

Assessment of the Precision of the Sherlock 3CG Tip Positioning System

NCT01275430 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2016-11-16

Study results available
· View outcomes & findings →

Summary

Phase I

* determine the location of the peripherally inserted central catheter (PICC) tip upon observation of maximum p-wave amplitude

Phase II

* determine the precision of PICC placement in the Sherlock 3CG group versus the standard PICC placement

Conditions

  • No Specific Conditions Under Study. Primary Focus: Adult Subjects Who Require PICC Placement

Interventions

DEVICE

Sherlock 3CG

Sherlock 3CG is indicated for central venous catheter guidance and positioning during catheter placement. The Sherlock 3CG provides real time catheter tip location information through the use of passive magnet and cardiac electrical signal detection.

OTHER

Blind Placement

PICCs will be placed "blindly", without the use of any tip location/positioning device.

Sponsors & Collaborators

  • C. R. Bard

    lead INDUSTRY

Principal Investigators

  • Gordon McLennan, M.D. · The Cleveland Clinic

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01275430 on ClinicalTrials.gov